ECJ Stock Chart & Stats
€235.70
€3.90(1.68%)
At close: 4:00 PM EDT
€235.70
€3.90(1.68%)
Day’s Range― - ―
52-Week Range€211.90 - €264.20
Previous CloseN/A
Volume21.00
Average Volume (3M)13.00
Market Cap
€69.51B
Enterprise Value€87.27K
Total Cash (Recent Filing)€519.80M
Total Debt (Recent Filing)€9.27B
Price to Earnings (P/E)37.7
Beta0.63
Next Earnings
Nov 03, 2026EPS Estimate
1.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.44
Shares Outstanding281,437,500
10 Day Avg. Volume3
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio-26.61
Price to Book (P/B)7.61
Price to Sales (P/S)4.62
P/FCF Ratio39.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€285.79Price Target Upside21.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)7.12
Revenue Forecast (FY)€15.61B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables + Services ModelEcolab’s mix of consumable chemistries, equipment and on-site services creates durable, recurring revenue and high route density. Long-term contracts, regulatory-driven hygiene needs and bundled service+product installs increase retention, enable cross-sell and stabilize revenue through cycles.
Improving Margins And Strong ROEReported margins and ROE have improved materially versus 2022–23, reflecting productivity, pricing and portfolio mix shifts. Sustained mid-teens operating margins (and a 20% target) support durable earnings power as higher-margin businesses scale and pricing protects margins versus input cost variability.
High-growth, Higher-margin PlatformsLife Sciences, Digital and Global High‑Tech are scaling rapidly, offering structural above-market growth and higher operating margins. These platforms drive margin mix improvement, recurring analytics/device revenue and long-term structural upside as connected devices and software adoption increases customer stickiness.
Bears Say
Weak Cash ConversionFree-cash-flow and cash-conversion lag reported earnings, with FCF growth softening recently. Persistent working-capital timing, capex for device scale-up, or lower cash conversion could limit discretionary investment capacity, slow debt paydown and constrain shareholder returns over the medium term.
Sizable Absolute Debt And New NotesAlthough leverage ratios improved, roughly $9B of absolute debt plus a $5B notes issuance increases exposure to refinancing and interest-rate risk. Elevated debt raises fixed obligations and reduces financial flexibility for future M&A, capex or shareholder returns if cash generation underperforms expectations.
Commodity Inflation & Acquisition DragSustained commodity cost pressure requires ongoing price recovery; incremental surcharges and pricing may lag. Recent M&A (Ovivo, CoolIT) brings near-term gross-margin drag, amortization and integration risk that can compress reported margins and delay realization of synergies over multiple quarters.
ECJ FAQ
What was Ecolab’s price range in the past 12 months?
Ecolab lowest stock price was €211.90 and its highest was €264.20 in the past 12 months.
What is Ecolab’s market cap?
Ecolab’s market cap is €69.51B.
When is Ecolab’s upcoming earnings report date?
Ecolab’s upcoming earnings report date is Nov 03, 2026 which is in 95 days.
How were Ecolab’s earnings last quarter?
Ecolab released its earnings results on Jul 28, 2026. The company reported €1.825 earnings per share for the quarter, beating the consensus estimate of €1.819 by €0.006.
Is Ecolab overvalued?
According to Wall Street analysts Ecolab’s price is currently Undervalued.
Does Ecolab pay dividends?
Ecolab does not currently pay dividends.
What is Ecolab’s EPS estimate?
Ecolab’s EPS estimate is 1.9.
How many shares outstanding does Ecolab have?
Ecolab has 281,437,500 shares outstanding.
What happened to Ecolab’s price movement after its last earnings report?
Ecolab reported an EPS of €1.825 in its last earnings report, beating expectations of €1.819. Following the earnings report the stock price went up 3.982%.
Which hedge fund is a major shareholder of Ecolab?
Currently, no hedge funds are holding shares in DE:ECJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ecolab Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€285.79 (21.25% Upside)
€285.79 (21.25% Upside)
Blogger Sentiment
Bullish
DE:ECJ Sentiment 75%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $155.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.66%
12-Months-Change
Fundamentals
Return on Equity
0.99%
Trailing 12-Months
Asset Growth
26.08%
Trailing 12-Months
Company Description
Ecolab
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
ECJ Company Deck
ECJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive outlook: the company reported strong Q2 operational performance with double‑digit EPS growth, accelerating organic sales, robust growth across multiple high‑margin businesses (Life Sciences, Digital, Pest, Global High‑Tech), increased 2026 EPS guidance, and an upgraded long‑term opportunity for high‑tech following CoolIT and Ovivo. Near‑term challenges include elevated commodity inflation, short‑term acquisition-related amortization and financing costs, margin drag from recent M&A, and regional disruptions (Middle East). Management emphasized the ability to recover costs via value-based pricing and affirmed targets (20% OI margin by 2027), suggesting confidence that highlights materially outweigh the manageable lowlights.View all DE:ECJ earnings summariesECJ Net sales Breakdown
47.76% Global Water
37.07% Global Institutional & Specialty
4.39% Global Life Sciences
7.58% Global Pest Elimination
0.00% Corporate
3.20% Effect of foreign currency translation

ECJ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€285.79
▲(21.25% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Air Products and Chemicals
―
PPG Industries
―
RPM International
―
Steris
―
DuPont de Nemours
―









